×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Event Driven Monitor – December 13, 2022

  • December 13, 2022
Quick updates on the event-driven strategies we follow on InsideArbitrage. Merger Arbitrage Horizon Therapeutics Public Limited Company (HZNP) to be acquired by Pillartree Limited, a newly formed private limited company wholly owned by Amgen (AMGN) for $28.3 billion or $116.50 per share in cash. Coupa Software Incorporated (COUP) to be acquired by Thoma Bravo for $8 billion or $81 per share in cash. Weber (WEBR) to be acquired by BDT Capital Partners LLC for $3.7 billion or $8.05 per share in cash. Meridian Bioscience (VIVO) announced that it has entered into a side letter with the buyer, setting the closing date of Meridian’s pending merger for January 31, 2023. Imago BioSciences (IMGO) announced that the tender offer launched by Merck (MRK) will expire on January 10, 2023. Ayala Pharmaceuticals (AYLA) announced that the special meeting of stockholders will be on January 13, 2023. Deals in the Works Veris Residential (VRE) in its letter, the Board details its unanimous rejection of each of Kushner Companies’ latest unsolicited proposals to acquire Veris Residential, as well as a go-forward process to facilitate constructive dialogue between Veris Residential and Kushner Companies. A potential deal we added on October 24, 2022, Weber (WEBR) announced that it accepted a buyout offer from BDT Capital Partners at...

Only plus or premium subscribers can access this post. Subscribe today.